Attorney General J.B. Van Hollen announced today that Wisconsin has joined with other states and the federal government and reached an agreement in principle with AstraZeneca Pharmaceuticals LP, to settle allegations it engaged in an off-label marketing campaign that improperly promoted the antipsychotic drug, Seroquel.
Two units of Johnson & Johnson will pay more than $81 million to resolve criminal and civil claims over illegal promotion of the epilepsy drug Topamax, the U.S. Justice Department said.
AstraZeneca PLC, in a settlement with the U.S. Justice Department, agreed to pay about $520 million to resolve allegations that the company improperly promoted the antipsychotic Seroquel.
On Christmas Eve it was announced that Boston Scientific has agreed to pay $22 million as it settles claims that one of its divisions gave kickbacks to doctors.
Dell has agreed to corporate governance changes as part of settlement with the SEC that was tied to its past financial reporting practices.
UBS, Switzerland’s largest bank, has agreed to settle charges of conspiracy to commit fraud against the U.S. and the IRS. UBS will pay $780 million and name names of some of its biggest clients. Raoul Weil of USB was recently declared a fugitive after failing to surrender to U.S. authorities on conspiring to help Americans shield assets from the IRS.
